サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427811

フィルフィニッシュ医薬品受託製造の世界市場レポート2024年

Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
フィルフィニッシュ医薬品受託製造の世界市場レポート2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

フィルフィニッシュ医薬品受託製造の市場規模は、今後数年間で大幅な成長が見込まれています。 9.3%の年間平均成長率（CAGR）で、2028年には171億米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療の拡大に加え、新興市場の機会、パンデミックへの備え、デジタル変革、持続可能性、グリーンイニシアチブに起因すると考えられます。予測期間の主な動向には、柔軟な製造ソリューション、パートナーシップ、コラボレーション、規制遵守、シリアル化が含まれます。さらに、自動化とロボティクスの統合だけでなく、持続可能性と環境に優しい実践にも重点が置かれています。

フィルフィニッシュ医薬品受託製造市場で予想される成長は、医薬品の需要の増加によって推進されています。医薬品には、人間または動物の病気を診断、予防、治療、または治癒するために配合された医薬品が含まれます。 フィルフィニッシュ医薬品受託製造は、注射剤、生物製剤、その他の医薬品を無菌充填する際に重要な役割を果たします。このサービスにより、精度、法規制への準拠、製造プロセスの合理化が保証され、高品質の製品が維持されます。たとえば、2022年 6月、欧州医薬品産業協会連合（EFPIA）は、2021年の欧州の医薬品総生産額が3,352億米ドル（2,866億9,700万ユーロ）から5%増加し、3,510億米ドル（300,000ユーロ）に達したと報告しました。スペインの製薬部門への研究開発投資も、2021年には前年比9.2%増の12億6,700万ユーロとなった。その結果、医薬品の需要の高まりがフィルフィニッシュ医薬品受託製造市場の成長を推進します。

増加する医薬品開発パイプラインは、フィルフィニッシュ医薬品受託製造市場を牽引する態勢が整っています。医薬品開発パイプラインは、最初の発見から市場での入手可能性まで、新しい医薬品または治療薬が通過する包括的なプロセスの概要を示します。このパイプラインでは、フィルフィニッシュ医薬品受託製造は、滅菌、バイアルまたは注射器への充填、密封、ラベル付けなどの医薬品製造の最終段階で外部委託されます。 2021年 11月の青島ECHEMI Digital Technology Co Ltd.のデータによると、世界の研究開発パイプラインは2021年に抗感染症薬が前年比22.4%増加しました。さらに、研究開発パイプラインのがん治療薬は2021年に合計6,961薬で、2020年から7.0%増加したことを示しています。したがって、医薬品開発パイプラインの拡大はフィルフィニッシュ医薬品受託製造市場の成長に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のフィルフィニッシュ医薬品受託製造市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のフィルフィニッシュ医薬品受託製造市場の規模実績と成長、2018年～2023年
  • 世界のフィルフィニッシュ医薬品受託製造市場の規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のフィルフィニッシュ医薬品受託製造市場、製品タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • プレフィルドシリンジ
  • バイアル
  • カートリッジ
  • その他の製品
  • 世界のフィルフィニッシュ医薬品受託製造市場、分子タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 高分子
  • 低分子
  • 世界のフィルフィニッシュ医薬品受託製造市場、エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • バイオ医薬品企業
  • 製薬会社

第7章 地域および国の分析

  • 世界のフィルフィニッシュ医薬品受託製造市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界のフィルフィニッシュ医薬品受託製造市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • フィルフィニッシュ医薬品受託製造市場の競合情勢
  • フィルフィニッシュ医薬品受託製造市場の企業プロファイル
    • AbbVie Inc.
    • Novartis AG
    • Thermo Fisher Scientific Inc.
    • Fresenius Kabi
    • Abbott Laboratories

第31章 その他の大手・革新的企業

  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Catalent Inc.
  • Sun Pharmaceutical Industries Limited
  • West Pharmaceutical Services Inc.
  • Patheon
  • Samsung Biologics Co.Ltd.
  • WuXi Biologics
  • Piramal Pharma Solutions
  • Pfizer CentreOne
  • Recipharm AB
  • Emergent BioSolutions Inc.
  • Boehringer Ingelheim BioXcellence
  • Corden Pharma GmbH
  • Aenova Group

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13655

Fill-finish pharmaceutical contract manufacturing involves outsourcing the final stages of the pharmaceutical manufacturing process to specialized contract manufacturing organizations (CMOs).

The primary product types in fill-finish pharmaceutical contract manufacturing include prefilled syringes, vials, cartridges, and other products. Prefilled syringes are pre-loaded with a specific dose of medication, ensuring precise dosing, sterility, and quality control through the aseptic fill-finish pharmaceutical contract manufacturing processes. This outsourcing approach is employed for both large molecules and small molecules, with biopharmaceutical companies and pharmaceutical companies serving as the key end-users.

The fill-finish pharmaceutical contract manufacturing research report is one of a series of new reports from The Business Research Company that provides fill-finish pharmaceutical contract manufacturing market statistics, including the fill-finish pharmaceutical contract manufacturing industry's global market size, regional shares, competitors with a fill-finish pharmaceutical contract manufacturing market share, detailed fill-finish pharmaceutical contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the fill-finish pharmaceutical contract manufacturing industry. This fill-finish pharmaceutical contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fill-finish pharmaceutical contract manufacturing market size has grown strongly in recent years. It will grow from $10.96 billion in 2023 to $11.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historical period can be attributed to the rising demand for biologics, outsourcing trends, the globalization of pharmaceutical supply chains, an emphasis on quality assurance, and cost containment measures.

The fill-finish pharmaceutical contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $17.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be attributed to emerging market opportunities, pandemic preparedness, digital transformation, sustainability, and green initiatives, along with the expansion of personalized medicine. Major trends in the forecast period encompass flexible manufacturing solutions, partnerships, and collaborations, regulatory compliance, and serialization. Additionally, there is a focus on sustainability and green practices, as well as the integration of automation and robotics.

The anticipated growth in the fill-finish pharmaceutical contract manufacturing market is driven by the increasing demand for pharmaceutical products. Pharmaceutical products encompass medications or drugs formulated to diagnose, prevent, treat, or cure diseases in humans or animals. Fill-finish pharmaceutical contract manufacturing plays a vital role in aseptically filling injectables, biologics, and other pharmaceutical products. This service ensures precision, regulatory compliance, and streamlined manufacturing processes, maintaining high-quality products. For example, in June 2022, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that the total pharmaceutical production in Europe reached $351 billion (€300,000 million) in 2021, reflecting a 5% increase from $335.2 billion (€286,697 million) in 2020. R&D investment in the Spanish pharmaceutical sector also rose by 9.2% to 1,267 million euros in 2021 compared to the previous year. Consequently, the growing demand for pharmaceutical products propels the fill-finish pharmaceutical contract manufacturing market's growth.

The increasing drug development pipeline is poised to drive the fill-finish pharmaceutical contract manufacturing market. The drug development pipeline outlines the comprehensive process a new pharmaceutical or therapeutic product undergoes, from initial discovery to market availability. In this pipeline, fill-finish pharmaceutical contract manufacturing is outsourced for the final stages of drug production, involving sterilization, filling into vials or syringes, sealing, and labeling. According to Qingdao ECHEMI Digital Technology Co Ltd. data from November 2021, the global research and development pipeline witnessed a 22.4% increase in anti-infective drugs in 2021 compared to the previous year. Additionally, the oncology drugs in the research and development pipeline totaled 6,961 drugs in 2021, indicating a 7.0% rise from 2020. Hence, the expanding drug development pipeline contributes to the growth of the fill-finish pharmaceutical contract manufacturing market.

Technological advancements emerge as a prominent trend in the fill-finish pharmaceutical contract manufacturing market. Companies within this sector are embracing innovative technologies to elevate product quality and adhere to stringent regulatory standards, ensuring their competitive position. For example, Steriline s.r.l., an Italy-based provider specializing in aseptic solutions, introduced robotic technologies tailored for small-batch aseptic filling in January 2023. These robotic systems enhance safety and flexibility in producing both toxic and non-toxic pharmaceutical drugs, minimizing the risk of human error, improving product quality, and optimizing operational efficiency.

Leading companies in the fill-finish pharmaceutical contract manufacturing market prioritize the integration of cutting-edge capabilities such as lyophilization technologies. Lyophilization capabilities involve a facility's expertise in the lyophilization process, or freeze-drying, which is crucial for drying and preserving biological or pharmaceutical products by removing water content through sublimation. In February 2022, Recro Pharma, Inc., a US-based contract development and manufacturing organization (CDMO), introduced Lyophilization Aseptic Fill/Finish to its range of services. This suite includes a sterile, automated vial filling system capable of filling up to 2,000 pre-sterilized vials per hour across various volumes. The equipment can lyophilize approximately 9,000 10 mL vials in each freeze-drying cycle, typically spanning 3-5 days.

In October 2021, PCI Pharma Services (PCI), a US-based provider of outsourced pharmaceutical services, acquired Lyophilization Services of New England Inc. (LSNE) for $1.5 billion. This strategic move expands PCI's capabilities in sterile injectables, lyophilization, and specialized formulation development and manufacturing. LSNE, a US-based contract development and manufacturing organization (CDMO), specializes in lyophilization, sterile fill-finish, and formulation development for pharmaceutical and biotechnology companies. The acquisition aligns LSNE's expertise with PCI's commitment to delivering integrated solutions for pharmaceutical companies.

Major companies operating in the fill-finish pharmaceutical contract manufacturing market report are AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi, Abbott Laboratories, Eurofins Scientific SE, Lonza Group Ltd., Catalent Inc., Sun Pharmaceutical Industries Limited, West Pharmaceutical Services Inc., Patheon, Samsung Biologics Co.Ltd., WuXi Biologics, Piramal Pharma Solutions, Pfizer CentreOne, Recipharm AB, Emergent BioSolutions Inc., Boehringer Ingelheim BioXcellence, Corden Pharma GmbH, Aenova Group, Baxter BioPharma Solutions , FUJIFILM Diosynth Biotechnologies, AGC Biologics, Rentschler Biopharma SE, Recro Pharma Inc., Cobra Biologics Limited, Grand River Aseptic Manufacturing (GRAM), MabPlex International Ltd., Cerbios-Pharma SA, Symbiosis Pharmaceutical Services Limited.

North America was the largest region in the fill-finish pharmaceutical contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fill-finish pharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fill-finish pharmaceutical contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fill-finish pharmaceutical contract manufacturing market includes revenues earned by entities by providing septic filling, packaging, labeling, and serialization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fill-finish pharmaceutical contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fill-finish pharmaceutical contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fill-finish pharmaceutical contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Prefilled Syringes; Vials; Cartridges; Other Products
  • 2) By Molecule Type: Large Molecules; Small Molecules
  • 3) By End-User: Biopharmaceutical Companies; Pharmaceutical Companies
  • Companies Mentioned: AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Fresenius Kabi; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fill-Finish Pharmaceutical Contract Manufacturing Market Characteristics

3. Fill-Finish Pharmaceutical Contract Manufacturing Market Trends And Strategies

4. Fill-Finish Pharmaceutical Contract Manufacturing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Size and Growth

  • 5.1. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Fill-Finish Pharmaceutical Contract Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Fill-Finish Pharmaceutical Contract Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fill-Finish Pharmaceutical Contract Manufacturing Market Segmentation

  • 6.1. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prefilled Syringes
  • Vials
  • Cartridges
  • Other Products
  • 6.2. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Large Molecules
  • Small Molecules
  • 6.3. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceutical Companies
  • Pharmaceutical Companies

7. Fill-Finish Pharmaceutical Contract Manufacturing Market Regional And Country Analysis

  • 7.1. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 8.1. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 9.1. China Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 9.2. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 10.1. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 11.1. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 11.2. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 12.1. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 13.1. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 14.1. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 14.2. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 15.1. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 15.2. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 16.1. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 17.1. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 18.1. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 19.1. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 20.1. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 21.1. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 21.2. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 22.1. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 23.1. North America Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 23.2. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 24.1. USA Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 24.2. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 25.1. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 25.2. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 26.1. South America Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 26.2. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 27.1. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 28.1. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 28.2. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 29.1. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 29.2. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Landscape
  • 30.2. Fill-Finish Pharmaceutical Contract Manufacturing Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Fresenius Kabi
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Fill-Finish Pharmaceutical Contract Manufacturing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Lonza Group Ltd.
  • 31.3. Catalent Inc.
  • 31.4. Sun Pharmaceutical Industries Limited
  • 31.5. West Pharmaceutical Services Inc.
  • 31.6. Patheon
  • 31.7. Samsung Biologics Co.Ltd.
  • 31.8. WuXi Biologics
  • 31.9. Piramal Pharma Solutions
  • 31.10. Pfizer CentreOne
  • 31.11. Recipharm AB
  • 31.12. Emergent BioSolutions Inc.
  • 31.13. Boehringer Ingelheim BioXcellence
  • 31.14. Corden Pharma GmbH
  • 31.15. Aenova Group

32. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Benchmarking

33. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fill-Finish Pharmaceutical Contract Manufacturing Market

35. Fill-Finish Pharmaceutical Contract Manufacturing Market Future Outlook and Potential Analysis

  • 35.1 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer